ライフサイエンスコーパス: provide informed consent

1 than 18 years, English-speaking, and able to provide informed consent.

2 o the ED and are clinically stable enough to provide informed consent.

3 nts or their proxies may not be available to provide informed consent.

4 in the area for 3 or more years, and able to provide informed consent.

5 information on colonoscopy and CRC risk, and provide informed consent.

6 the intervention subsequently approached to provide informed consent.

7 ognitive impairment impacting the ability to provide informed consent.

8 reside in the area for more than 1 year, and provided informed consent.

9 s prospective single-arm study, and patients provided informed consent.

10 isease, no psychosis, were not pregnant, and provided informed consent.

11 Results: Four patients provided informed consent.

12 OP at 1 of 6 major ROP centers whose parents provided informed consent.

13 -controlled clinical trial, and all patients provided informed consent.

14 All subjects provided informed consent.

15 All participants provided informed consent.

16 onal review board approval, and all subjects provided informed consent.

17 All study patients provided informed consent.

18 for participation in the ICU, of which 1458 provided informed consent.

19 ved the study protocol, and all participants provided informed consent.

20 s; age range, 47-81 years) were enrolled and provided informed consent.

21 tutional review board approval; participants provided informed consent.

22 itutional review board approval and patients provided informed consent.

23 Patients provided informed consent.

24 ethics committee, and all 20 adult patients provided informed consent.

25 d at each screening center; all participants provided informed consent.

26 titutional review board and each participant provided informed consent.

27 All study participants provided informed consent.

28 pproved the study protocol, and all patients provided informed consent.

29 nd their candidacy for surgical intervention provided informed consent.

30 institutional review board, and all subjects provided informed consent.

31 the local ethics committee, and all patients provided informed consent.

32 tutional review board approval; all patients provided informed consent.

33 oved the HIPAA-compliant study; all patients provided informed consent.

34 institutional review board; all participants provided informed consent.

35 All patients provided informed consent.

36 ard approval, and patients in the CLQ cohort provided informed consent.

37 board approved this study, and all subjects provided informed consent.

38 nderwent screening FFDM during 2004-2013 and provided informed consent.

39 (Project ID: 14895/005) and all participants provided informed consent.

40 MR-guided focused ultrasound ablation after providing informed consent.

41 went echo-planar spectroscopic imaging after providing informed consent.

42 derwent standard ophthalmic evaluation after providing informed consent.

43 help in developing more effective methods of providing informed consent.

44 nt of conditions other than malaria, and not providing informed consent.

45 After providing informed consent, 108 patients with recently u

46 After providing informed consent, 24 adult volunteers underwen

47 umber listed in the electronic health record provided informed consent after ED discharge, and data w

48 ved at least 1 dose of either treatment, and provided informed consent after surgery.

49 vention designed to improve their ability to provide informed consent and were then retested.

50 on-to-treat population (ie, all patients who provided informed consent and allocated a randomisation

51 Participants provided informed consent and completed a survey (paper

52 ipants were those aged 18 years or older who provided informed consent and possessed a valid RDS refe

53 S (eight men, two women; mean age, 41 years) provided informed consent and underwent 3.0-T MR imaging

54 d peer navigators, being willing and able to provide informed consent, and being willing to provide a

55 25 years, in good general health, willing to provide informed consent, and were not pregnant or breas

56 HIV, were not too impaired to comprehend and provide informed consent, and, for this paper, who teste

57 Participants provided informed consent, and additional assent was obt

58 All study subjects provided informed consent, and all private health inform

59 aging Network National CT Colonography Trial provided informed consent, and approval was obtained fro

60 Of these, 3040 patients met study criteria, provided informed consent, and completed baseline assess

61 The patient provided informed consent, and the study was conducted i

62 Sixteen patients presented with an AVM, provided informed consent, and were prospectively includ

63 y eligibility; 131 met eligibility criteria, provided informed consent, and were randomized to either

64 atory response; pain caused by cIAI; able to provide informed consent; and diagnosis of cIAI with son

65 Each patient provided informed consent before undergoing CT.

66 cluded being aged 18 to 70 years, capable of providing informed consent, English speaking or having E

67 ts agreed or disagreed that patients need to provide informed consent for AI model use during cancer

68 ability of individuals with schizophrenia to provide informed consent for research has become the foc

69 with schizophrenia and subjects with HIV to provide informed consent for research participation and

70 Patients with a diagnosis of cancer provided informed consent for enrollment on a study perm

71 subjects with at least one CAD risk factor) provided informed consent for participation in this inst

72 All patients provided informed consent for study inclusion.

73 After providing informed consent for a trial but before receiv

74 oard-approved study, all patients with ADPKD provided informed consent; for control subjects, informe

75 All volunteers (n = 12) provided informed consent in accordance with institution

76 urteen age- and sex-matched control subjects provided informed consent in accordance with the institu

77 erials and Methods Thirty recruited patients provided informed consent in this institutional review b

78 All patients provided informed consent in this institutional review b

79 mmography Registry between 2006 and 2012 and provided informed consent or a waiver for research, in c

80 ed diagnosis of SARS-CoV-2 infection who had provided informed consent or assent were consecutively e

81 the exclusion criteria were being unable to provide informed consent, or being too ill or distressed

82 research is whether participants are able to provide informed consent, particularly for protocols ent

83 estions about suicidal patients' capacity to provide informed consent, the risk of some lethal outcom

84 After providing informed consent, the participants were invite

85 ioning, psychiatric symptoms, and ability to provide informed consent to a hypothetical drug trial.

86 Kidney transplant candidates (KTCs) must provide informed consent to accept kidneys from increase

87 atric symptoms and cognitive dysfunction can provide informed consent to participate in research is a

88 D) grade U (unclassified) or grade I-IV COPD provided informed consent to an ethics board-approved HI

89 ods Eighteen patients with biopsy-proven PCa provided informed consent to be included in this institu

90 prior mammograms and additional risk factors provided informed consent to enroll in an institutional

91 al football players (age range, 52-65 years) provided informed consent to participate in this cross-s

92 All participants provided informed consent to participate in this study,

93 All participants provided informed consent to participate in this study,

94 by the local ethics board, and all patients provided informed consent to participate.

95 All participants provided informed consent to take part in the trial.

96 An approach to providing informed consent to breast cancer survivors co

97 y volunteers (median age, 22.5 years), after providing informed consent, underwent MR imaging while m

98 ho spoke either English or Luganda and could provide informed consent were eligible for participation

99 5 years and individuals without capacity to provide informed consent were excluded.

100 ime in direct patient care, and were able to provide informed consent were included.

101 21, vaccinated PAs aged >=18 years who could provide informed consent were recruited during vaccinati

102 Candidates for SNS who provided informed consent were enrolled in this Institut

103 ts at Eastern State Hospital in Kentucky who provided informed consent were genotyped at the CYP2D6 l

104 All patients who provided informed consent were included in the safety an

105 omputed tomographic (CT) angiography and who provided informed consent were prospectively randomized

106 Samples from 3,187 individuals who provided informed consent were tested in parallel using

107 kle cell pain crises within 12 months before providing informed consent, were randomly assigned 1:1:1

108 Exclusions were inability to provide informed consent (where required) or unavailabil

109 to hospital in the past 36h; and (d) able to provide informed consent will be eligible to participate

110 Any patients who provided informed consent within 14 days of admission to

111 etus without major anomalies, and ability to provide informed consent, without pre-eclampsia or parti